Subject: Science and tech Context: Biocon has gotten approval of DGCI nod to market Itolizumab for Covid treatment Concept: It is a drug used to cure skin ailment psoriasis It is approved for restricted emergency use for the treatment of cytokine’ release syndrome in moderate to severe acute respiratory distress syndrome patients due to Covid-19